Australia markets open in 8 hours 9 minutes

Nurosene Health Inc. (8TV.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.2340+0.0020 (+0.86%)
As of 05:03PM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 10.05M
Enterprise value 8.65M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)175.75
Price/book (mrq)0.76
Enterprise value/revenue 115.33
Enterprise value/EBITDA -0.95

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-86.31%
S&P500 52-week change 3-11.08%
52-week high 31.6950
52-week low 30.1810
50-day moving average 30.2560
200-day moving average 30.6276

Share statistics

Avg vol (3-month) 3596
Avg vol (10-day) 3N/A
Shares outstanding 540.29M
Implied shares outstanding 6N/A
Float 834.19M
% held by insiders 120.71%
% held by institutions 13.32%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 30 Sept 2021
Most-recent quarter (mrq)31 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-12,627.46%

Management effectiveness

Return on assets (ttm)-59.13%
Return on equity (ttm)-101.25%

Income statement

Revenue (ttm)74.98k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-9.51M
Diluted EPS (ttm)-0.2030
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)515.98k
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)1.96
Book value per share (mrq)0.43

Cash flow statement

Operating cash flow (ttm)-6.7M
Levered free cash flow (ttm)-1.97M